Immune Pharmaceuticals of Delaware you will have 100% loss
Cytoviatx is a separate company and immune pharmaceuticals shareholders will receive absolutely nothing to state otherwise is disingenuous.
Letterpenny think of the bright side total wipeout.
Immune pharmaceuticals of Delaware has no officers or directors
CFTC v. Weintraub, 471 U.S. 343, 353 (1985) (“Congress contemplated that when a trustee is appointed, he assumes control of the business, and the debtor’s directors are ‘completely ousted.’”)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.